Angela – Interview 23
Angela was diagnosed with Parkinson’s disease after taking part in a trial on nerve conduction. She has since been in a randomised trial of different drugs for Parkinson’s and would happily take part in another trial, despite having had side effects.(Angela is also on our Parkinson’s disease site, Interview 10).
Angela had been worried she was losing the use of her left side for several years. Her GP told her there was a trial of a nerve conduction test running at her local hospital and so she took part. The results showed there was nothing wrong with her nerve impulses, but the consultant noticed that the muscles in her left arm were atrophied (starting to waste away). She was diagnosed with Parkinson’s disease. It was a relief to know what was wrong and be able to start treatment.
At her first hospital appointment after diagnosis, she was invited to take part in a randomised controlled trial of four different drugs for Parkinson’s. She would be randomly allocated to one of the four drugs and would be asked to take it for a minimum of a week. She and her husband decided immediately that this was an important project they wanted to contribute to. After randomisation the consultant told Angela she had been allocated to the group taking Sinemet (a combination of levodopa and carbidopa), and that this would not have been his chosen treatment for her. She was a bit worried about this as she had a friend who had bad side effects from Sinemet, but she decided to go ahead.
Angela took Sinemet for the minimum period, and had very unpleasant side effects, including fainting, falling and slurred speech. She informed the hospital of her symptoms, but was determined to stay in the trial, as she feels it is the only way we can improve knowledge of what works and what does not. She felt she had made a commitment to the trial which she should honour. Knowing that it was only for a short period helped. After the minimum period she was changed to a different drug in the trial, ropinirole, which she still takes. Every few months she and her husband fill in questionnaires monitoring her symptoms and aspects of her quality of life. She has excellent support from the consultant and the research nurse, and can contact them any time.
She is worried that the emphasis in the media tends to be on things that go wrong with trials, and believes more needs to be done to present good news stories about the value of trials and why people should think about taking part. She would also like more trials carried out on complementary therapies – she personally feels she has benefited from acupuncture.
Angela is concerned about payment being offered to take part in trials. She thinks it is something people should do because it is morally right, rather than looking for a reward. She herself would definitely want to take part in any further trials if invited, including placebo-controlled trials. She knows that in any randomised trial you cannot be sure if you will get the treatment you think you would prefer, but that is necessary for ensuring that you get a random mix of people in each group for a fair comparison. (Angela is also on our Parkinson’s disease site, Interview 10).